{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:59:21Z","timestamp":1786996761183,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","semarthritisrheumatism.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.semarthrit.2015.03.004","type":"journal-article","created":{"date-parts":[[2015,4,20]],"date-time":"2015-04-20T23:46:32Z","timestamp":1429573592000},"page":"60-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Rituximab for eosinophilic granulomatosis with polyangiitis with severe vasculitic neuropathy: Case report and review of current clinical evidence"],"prefix":"10.1016","volume":"45","author":[{"given":"Antonis","family":"Fanouriakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Kougkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Vassilopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Fragouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1044-2449","authenticated-orcid":false,"given":"Argyro","family":"Repa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prodromos","family":"Sidiropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2015.03.004_bib1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/BOR.0b013e32834d85ce","article-title":"Churg\u2013Strauss syndrome: update on pathophysiology and treatment","volume":"24","author":"Vaglio","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaci.2010.03.042","article-title":"Refining the definition of hypereosinophilic syndrome","volume":"126","author":"Simon","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib5","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/ard.2008.093773","article-title":"Severe bronchospasm associated with rituximab for refractory Churg\u2013Strauss syndrome","volume":"68","author":"Bouldouyre","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib6","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1093\/ndt\/gfq852","article-title":"Rituximab for the treatment of Churg\u2013Strauss syndrome with renal involvement","volume":"26","author":"Cartin-Ceba","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.semarthrit.2015.03.004_bib7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/ajh.23791","article-title":"Refractory warm IgM-mediated autoimmune hemolytic anemia associated with Churg\u2013Strauss syndrome responsive to eculizumab and rituximab","volume":"90","author":"Chao","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib8","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s00415-013-7217-3","article-title":"Spinal hemorrhage in eosinophilic granulomatosis with polyangiitis (Churg\u2013Strauss)","volume":"261","author":"Diamanti","year":"2014","journal-title":"J Neurol"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00296-009-1146-6","article-title":"Churg\u2013Strauss syndrome successfully treated with rituximab","volume":"31","author":"Donvik","year":"2011","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib10","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1093\/rheumatology\/keu290","article-title":"B cell depletion therapy and eosinophilic granulomatosis with polyangiitis with hepatic involvement","volume":"53","author":"Grigoriou","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib11","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1136\/ard.2005.047308","article-title":"Successful use of rituximab in a patient with recalcitrant Churg\u2013Strauss syndrome","volume":"65","author":"Kaushik","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib12","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/ard.2005.042937","article-title":"Rituximab in Churg\u2013Strauss syndrome","volume":"65","author":"Koukoulaki","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/ndt\/gfn430","article-title":"Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-centre experience with 15 patients","volume":"24","author":"Lovric","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib14","first-page":"737","article-title":"Treatment-resistant Churg\u2013Strauss syndrome: progression after five years using rituximab","volume":"33","author":"Martinez-Villaescusa","year":"2013","journal-title":"Nefrologia"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib15","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/rheumatology\/ken175","article-title":"Rituximab is effective in the treatment of refractory Churg\u2013Strauss syndrome and is associated with diminished T-cell interleukin-5 production","volume":"47","author":"Pepper","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib16","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s10067-011-1756-8","article-title":"Long-term follow-up of different refractory systemic vasculitides treated with rituximab","volume":"30","author":"Rees","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000329535","article-title":"Long-term effects of rituximab added to cyclophosphamide in refractory patients with vasculitis","volume":"34","author":"Roccatello","year":"2011","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib18","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/ard.2009.109850","article-title":"Successful use of rituximab in a patient with Churg\u2013Strauss syndrome and refractory central nervous system involvement","volume":"69","author":"Saech","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib19","doi-asserted-by":"crossref","first-page":"R133","DOI":"10.1186\/ar4313","article-title":"Rituximab in the treatment of refractory or relapsing eosinophilic granulomatosis with polyangiitis (Churg\u2013Strauss syndrome)","volume":"15","author":"Thiel","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib20","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3109\/14397595.2013.874734","article-title":"Successful treatment of eosinophilic granulomatosis with polyangiitis (EGPA; formerly Churg\u2013Strauss syndrome) with rituximab in a case refractory to glucocorticoids, cyclophosphamide, and IVIG","volume":"24","author":"Umezawa","year":"2014","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib21","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1002\/art.22046","article-title":"Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: remission, relapse, and re-treatment","volume":"54","author":"Smith","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib22","article-title":"Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg\u2013Strauss)","author":"Mohammad","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib23","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1002\/art.24637","article-title":"A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis","volume":"60","author":"Jones","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib24","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/art.37721","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg\u2013Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort","volume":"65","author":"Comarmond","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib25","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2012-201531","article-title":"A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg\u2013Strauss, EGPA): monocentric experiences in 150 patients","volume":"72","author":"Moosig","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib26","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3109\/08916934.2012.677078","article-title":"Association of ANCA-associated vasculitis\u2013rheumatoid arthritis overlap syndrome in four patients: rituximab may be the right choice?","volume":"45","author":"Szilasi","year":"2012","journal-title":"Autoimmunity"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.autrev.2011.07.005","article-title":"Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature","volume":"11","author":"Ferri","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib28","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/art.34331","article-title":"A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis","volume":"64","author":"De Vita","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib29","first-page":"468","article-title":"Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases","volume":"28","author":"Ramos-Casals","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib30","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/ard.2011.153601","article-title":"Rituximab for refractory granulomatosis with polyangiitis (Wegener\u05f3s granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations","volume":"71","author":"Holle","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib31","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2796.2005.01494.x","article-title":"Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab","volume":"257","author":"Eriksson","year":"2005","journal-title":"J Intern Med"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib32","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/WCO.0b013e3283580432","article-title":"The vasculitic neuropathies: an update","volume":"25","author":"Collins","year":"2012","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s004150050562","article-title":"Quality of life in patients with axonal polyneuropathy","volume":"247","author":"Teunissen","year":"2000","journal-title":"J Neurol"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib34","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1093\/rheumatology\/ker266","article-title":"Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials","volume":"50","author":"Suppiah","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib35","doi-asserted-by":"crossref","first-page":"632","DOI":"10.7326\/0003-4819-143-9-200511010-00006","article-title":"Antineutrophil cytoplasmic antibodies and the Churg\u2013Strauss syndrome","volume":"143","author":"Sable-Fourtassou","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib36","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/ard.2005.044420","article-title":"Lack of efficacy of rituximab in Wegener\u05f3s granulomatosis with refractory granulomatous manifestations","volume":"65","author":"Aries","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib37","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/art.24454","article-title":"Rituximab is effective in the treatment of refractory ophthalmic Wegener\u05f3s granulomatosis","volume":"60","author":"Taylor","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib38","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1749-4486.2009.01968.x","article-title":"B-cell depletion with rituximab for refractory head and neck Wegener\u05f3s granulomatosis: a cohort study","volume":"34","author":"Martinez Del Pero","year":"2009","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib39","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/rheumatology\/ker150","article-title":"Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis","volume":"51","author":"Guerry","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib40","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1002\/art.27678","article-title":"CCL17\/thymus and activation-related chemokine in Churg\u2013Strauss syndrome","volume":"62","author":"Dallos","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.03.004_bib41","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1182\/blood-2010-02-267542","article-title":"Interleukin-25: a cytokine linking eosinophils and adaptive immunity in Churg\u2013Strauss syndrome","volume":"116","author":"Terrier","year":"2010","journal-title":"Blood"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017215000530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017215000530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T15:48:43Z","timestamp":1747928923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017215000530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0049017215000530"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2015.03.004","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rituximab for eosinophilic granulomatosis with polyangiitis with severe vasculitic neuropathy: Case report and review of current clinical evidence","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2015.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}